Can the choice of artificial tears harm patients? A narrative review with an overview of the Nordic market

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: K. N. Mikha, C. E. Ø. Rasmussen, S. N. G. Ahrensberg, J. Freiberg, R. A. Wozniak, U. M. K. Alnoor, F. Fineide, T. P. Utheim, S. Heegaard, M. Kolko
Format: Artículo Open Access
Published: Wiley 2025
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867006305147813888
author K. N. Mikha
C. E. Ø. Rasmussen
S. N. G. Ahrensberg
J. Freiberg
R. A. Wozniak
U. M. K. Alnoor
F. Fineide
T. P. Utheim
S. Heegaard
M. Kolko
author_facet K. N. Mikha
C. E. Ø. Rasmussen
S. N. G. Ahrensberg
J. Freiberg
R. A. Wozniak
U. M. K. Alnoor
F. Fineide
T. P. Utheim
S. Heegaard
M. Kolko
K. N. Mikha
C. E. Ø. Rasmussen
S. N. G. Ahrensberg
J. Freiberg
R. A. Wozniak
U. M. K. Alnoor
F. Fineide
T. P. Utheim
S. Heegaard
M. Kolko
collection Wiley Open Access
contents Can the choice of artificial tears harm patients? A narrative review with an overview of the Nordic market K. N. Mikha C. E. Ø. Rasmussen S. N. G. Ahrensberg J. Freiberg R. A. Wozniak U. M. K. Alnoor F. Fineide T. P. Utheim S. Heegaard M. Kolko Acta Ophthalmologica AbstractPurposeTo provide an overview of artificial tears marketed in the following Nordic countries: Denmark, Finland, Norway, Iceland and Sweden. Furthermore, this review aimed to highlight the different preservatives and other constituents found in artificial tears in the Nordic market, focussing on adverse effects.MethodsArtificial tears appearing in online pharmacies in Denmark, Norway, Sweden, Finland and Iceland were included, and tables listing their components were created. Based on the preservatives and other constituents found in the artificial tears on the Nordic market, a literature search was conducted to investigate differences and potential adverse effects. This was achieved using PubMed with MeSH and free text search terms. Included articles were (i) studies performed on humans in vivo or in vitro human models, (ii) published between 2000 and 2023 and (iii) focussing on adverse effects, preservatives, toxicity, other constituents and preservative‐free artificial tears.ResultsA total of 88 artificial tears were found on the Nordic market. Approximately 32% (28 out of 88) of the artificial tears contain preservatives. Eleven of these are preserved with benzalkonium chloride (BAK) or cetrimide. After a thorough literature search, evidence has been found for the toxic effects of BAK and cetrimide. There is no evidence of toxic effects of lubricants, osmoprotectants and lipids.ConclusionsThe findings of this review highlight the paradoxical fact that many treatments for ocular surface diseases contain toxic preservatives that may lead to worsening of the condition. In particular, long‐time toxic effects of BAK may contribute to disease progression. 10.1111/aos.17455 http://creativecommons.org/licenses/by-nc-nd/4.0/
doi_str_mv 10.1111/aos.17455
format Artículo Open Access
id wiley_oa_10_1111_aos_17455
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Can the choice of artificial tears harm patients? A narrative review with an overview of the Nordic market
K. N. Mikha
C. E. Ø. Rasmussen
S. N. G. Ahrensberg
J. Freiberg
R. A. Wozniak
U. M. K. Alnoor
F. Fineide
T. P. Utheim
S. Heegaard
M. Kolko
Acta Ophthalmologica
Can the choice of artificial tears harm patients? A narrative review with an overview of the Nordic market K. N. Mikha C. E. Ø. Rasmussen S. N. G. Ahrensberg J. Freiberg R. A. Wozniak U. M. K. Alnoor F. Fineide T. P. Utheim S. Heegaard M. Kolko Acta Ophthalmologica AbstractPurposeTo provide an overview of artificial tears marketed in the following Nordic countries: Denmark, Finland, Norway, Iceland and Sweden. Furthermore, this review aimed to highlight the different preservatives and other constituents found in artificial tears in the Nordic market, focussing on adverse effects.MethodsArtificial tears appearing in online pharmacies in Denmark, Norway, Sweden, Finland and Iceland were included, and tables listing their components were created. Based on the preservatives and other constituents found in the artificial tears on the Nordic market, a literature search was conducted to investigate differences and potential adverse effects. This was achieved using PubMed with MeSH and free text search terms. Included articles were (i) studies performed on humans in vivo or in vitro human models, (ii) published between 2000 and 2023 and (iii) focussing on adverse effects, preservatives, toxicity, other constituents and preservative‐free artificial tears.ResultsA total of 88 artificial tears were found on the Nordic market. Approximately 32% (28 out of 88) of the artificial tears contain preservatives. Eleven of these are preserved with benzalkonium chloride (BAK) or cetrimide. After a thorough literature search, evidence has been found for the toxic effects of BAK and cetrimide. There is no evidence of toxic effects of lubricants, osmoprotectants and lipids.ConclusionsThe findings of this review highlight the paradoxical fact that many treatments for ocular surface diseases contain toxic preservatives that may lead to worsening of the condition. In particular, long‐time toxic effects of BAK may contribute to disease progression. 10.1111/aos.17455 http://creativecommons.org/licenses/by-nc-nd/4.0/
title Can the choice of artificial tears harm patients? A narrative review with an overview of the Nordic market
topic Acta Ophthalmologica
url https://onlinelibrary.wiley.com/doi/10.1111/aos.17455